25 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
by MAIA Enabling MAIA-2021-029 Multiple Indications 4
NYSE American: MAIA MISSION AND APPROACH 5 5
NYSE American: MAIA Population aged80 expected
FWP
MAIA
MAIA Biotechnology Inc
11 Jul 23
Free writing prospectus
12:42pm
-IND development one agent every 12 months 6
MISSION AND APPROACH 7 7
Population aged80 expected to triple by Cancer is the 2050 most dominant age
FWP
MAIA
MAIA Biotechnology Inc
9 Jun 23
Free writing prospectus
6:47am
: advance to pre-IND development one agent 6 every 12 months
MISSION AND APPROACH 7 7
Population aged80 expected to triple by Cancer is the 2050
DRS
suolbn
1 Jun 23
Draft registration statement
12:00am
424B4
anrog xg31unxen37ej
25 Apr 23
Prospectus supplement with pricing info
7:45pm
FWP
666d5d3jd s1
20 Apr 23
Free writing prospectus
9:38am
FWP
jtasn5
18 Apr 23
Free writing prospectus
3:08pm
FWP
fplb7
11 Apr 23
Free writing prospectus
8:30am
FWP
13sl496fc439nix2cauq
6 Apr 23
Free writing prospectus
6:24pm
DRS
worrh8ccmlcbjsw8q
23 Dec 22
Draft registration statement
12:00am
424B4
cyy38xfa7amxse18 hq
29 Jul 22
Prospectus supplement with pricing info
8:31am